Summary of demographics and baseline characteristics
| Characteristic . | N = 299 . |
|---|---|
| Median age, y (min-max) | 50.0 (18-86) |
| Sex, n (%) | |
| Women | 198 (66) |
| Ethnicity, n (%) | |
| White | 237 (79) |
| Asian | 45 (15) |
| Other | 17 (6) |
| Baseline platelets, n (%) | |
| ≤ 15 000/μL | 128 (43) |
| > 15 000/μL to < 30 000/μL | 80 (27) |
| 30 000/μL to 50 000/μL | 52 (17) |
| > 50 000/μL | 39 (13) |
| Prior therapies, n (%)* | |
| 1 | 67 (22) |
| 2 | 73 (24) |
| 3 | 47 (16) |
| ≥ 4 | 112 (37) |
| Splenectomy, n (%) | |
| Yes | 115 (38) |
| Concomitant ITP medication, n (%) | |
| Yes | 100 (33) |
| Characteristic . | N = 299 . |
|---|---|
| Median age, y (min-max) | 50.0 (18-86) |
| Sex, n (%) | |
| Women | 198 (66) |
| Ethnicity, n (%) | |
| White | 237 (79) |
| Asian | 45 (15) |
| Other | 17 (6) |
| Baseline platelets, n (%) | |
| ≤ 15 000/μL | 128 (43) |
| > 15 000/μL to < 30 000/μL | 80 (27) |
| 30 000/μL to 50 000/μL | 52 (17) |
| > 50 000/μL | 39 (13) |
| Prior therapies, n (%)* | |
| 1 | 67 (22) |
| 2 | 73 (24) |
| 3 | 47 (16) |
| ≥ 4 | 112 (37) |
| Splenectomy, n (%) | |
| Yes | 115 (38) |
| Concomitant ITP medication, n (%) | |
| Yes | 100 (33) |
ITP indicates immune thrombocytopenia.
Including splenectomy.